Subscribe To
HOOKIPA Pharma Reports First Quarter 2023 Financial Results and Recent Business Highlights
HOOKIPA on track to report Phase 2 data on HB-200 for head and neck cancer in combination with pembrolizumab in 2Q 2023 Phase 1 clinical trials initiated for two programs (HB-300 for advanced prostate cancer and Gilead-partnered HB-400 for chronic hepatitis B) HB-700 for KRAS-mutated cancers achieved $10 million milestone payment in Roche collaboration NEW […] The post HOOKIPA Pharma Reports First Quarter 2023 Financial Results and Recent Business Highlights appeared first on ForexTV...
Read More
Posted: May 11 2023, 11:01
Author Name: forextv
Views: 101923